Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
作者信息
Locker G Y, Hoeltgen T, Kilton L, Krauss S, McNamara M, Blough R, Johnson C
出版信息
Cancer Treat Rep. 1987 Jul-Aug;71(7-8):765-6.
PMID:3300969
Abstract
摘要
相似文献
1
Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.表柔比星用于晚期结直肠癌且未接受过化疗患者的II期研究：伊利诺伊州癌症协会试验
Cancer Treat Rep. 1987 Jul-Aug;71(7-8):765-6.
2
Phase II trial of esorubicin in patients with advanced colorectal carcinoma.表柔比星用于晚期结直肠癌患者的II期试验。
Cancer Treat Rep. 1986 Oct;70(10):1241-2.
3
Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
Cancer Treat Rep. 1987 Jun;71(6):649-50.
4
Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
Cancer Treat Rep. 1985 Jan;69(1):143-4.
5
Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
Cancer Treat Rep. 1987 Sep;71(9):871-2.
6
Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
Cancer Treat Rep. 1986 Feb;70(2):307-8.
7
Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
Cancer Treat Rep. 1984 Oct;68(10):1303-4.
8
Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.吡唑呋喃对晚期结直肠癌患者的II期评估。
Cancer Treat Rep. 1979 Jan;63(1):139-40.
9
Phase II trial of ifosfamide and mesna in advanced colorectal cancer.
Cancer Treat Rep. 1987 Jun;71(6):663-4.
10
Phase II trial of bisantrene in advanced colorectal carcinoma.比生群用于晚期结直肠癌的II期试验。
Cancer Treat Rep. 1983 Mar;67(3):307-8.
引用本文的文献
1
Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
Invest New Drugs. 1989 Jul;7(2-3):235-8. doi: 10.1007/BF00170865.
2
Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.
Invest New Drugs. 1989 Nov;7(4):333-6. doi: 10.1007/BF00173763.
3
Phase II study of 4'-deoxydoxorubicin (esorubicin) in advanced or metastatic adenocarcinoma of the stomach.
Invest New Drugs. 1991 Feb;9(1):83-5. doi: 10.1007/BF00194552.
Zotero 插件